Self-sampling for cervical cancer screening: Empowering women to lead a paradigm change in cancer control

Affiliations

E L Franco. Curr Oncol. 2018 Feb.

. 2018 Feb;25(1):e1-e3.

doi: 10.3747/co.25.3969. Epub 2018 Feb 28.

No abstract available

References

1. Fischer S. Inexpensive population screening for abnormal cells from the uterine cervix and valid results using the vaginal cytopipette. Gynecol Oncol. 1992;46:62–4. doi: 10.1016/0090-8258(92)90197-Q. - DOI - PubMed
1. Morrison EAB, Goldberg GL, Hagan RJ, Kadish AS, Burk RD. Self-administered home cervicovaginal lavage: a novel tool for the clinical epidemiologic investigation of genital human papillomavirus infection. Am J Obstet Gynecol. 1992;167:104–7. doi: 10.1016/S0002-9378(11)91637-8. - DOI - PubMed
1. Moscicki AB. Comparison between methods for human papillomavirus dna testing: a model for self-testing in young women. J Infect Dis. 1993;167:723–5. doi: 10.1093/infdis/167.3.723. - DOI - PubMed
1. Tota JE, Bentley J, Blake J, et al. Introduction of molecular hpv testing as the primary technology in cervical cancer screening: acting on evidence to change the current paradigm. Prev Med. 2017;98:5–14. doi: 10.1016/j.ypmed.2016.11.029. - DOI - PubMed
1. Tota JE, Bentley J, Blake J, et al. Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening. Prev Med. 2017;98:15–20. doi: 10.1016/j.ypmed.2016.11.030. - DOI - PubMed